TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW
PRESS RELEASES

Axcella Announces Upcoming Presentation At J.P. Morgan Healthcare Conference

  • By Business Wire
  • Jan 5, 2021 7:58 AM EST
PRESS RELEASES

Axcella Announces Upcoming Investor Conference Presentation

  • By Business Wire
  • Nov 20, 2020 7:30 AM EST
PRESS RELEASES

Axcella To Report Third Quarter 2020 Financial Results And Hold Conference Call On November 12, 2020

  • By Business Wire
  • Oct 29, 2020 8:00 AM EDT
PRESS RELEASES

Axcella Announces Upcoming Presentations At AASLD's The Liver MeetingĀ® 2020

  • By Business Wire
  • Oct 2, 2020 7:58 AM EDT
PRESS RELEASES

New Publication Highlights Therapeutic Potential Of Endogenous Metabolic Modulators (EMMs)

  • By Business Wire
  • Sep 30, 2020 7:28 AM EDT
PRESS RELEASES

Axcella Announces Upcoming Investor Conference Presentation

  • By Business Wire
  • Sep 29, 2020 7:58 AM EDT
PRESS RELEASES

Axcella's Late-Breaker Data From AXA1125-003 Clinical Study Presented At The EASL Digital International Liver Congress

  • By Business Wire
  • Aug 27, 2020 8:00 AM EDT
PRESS RELEASES

Axcella Announces Upcoming Later-Breaker Presentation At The Digital International Liver Congress 2020

  • By Business Wire
  • Aug 20, 2020 7:30 AM EDT
PRESS RELEASES

Results Of Axcella's AXA1665-001 Clinical Study Published In Clinical And Translational Gastroenterology

  • By Business Wire
  • Aug 17, 2020 7:30 AM EDT
PRESS RELEASES

Axcella To Report Second Quarter 2020 Financial Results And Hold Conference Call On August 5, 2020

  • By Business Wire
  • Aug 3, 2020 8:00 AM EDT
PRESS RELEASES

Flagship Pioneering's Scientists Invent A New Category Of Genome Engineering Technology: Gene Writing

  • By PR Newswire
  • Jul 7, 2020 8:00 AM EDT
PRESS RELEASES

Axcella Announces Patent Issuances Covering AXA1665

  • By Business Wire
  • Jun 17, 2020 8:00 AM EDT
PRESS RELEASES

Axcella To Present At Goldman Sachs 41st Annual Global Healthcare Conference

  • By Business Wire
  • Jun 3, 2020 8:00 AM EDT
PRESS RELEASES

Axcella Announces Closing Of Public Offering Of Common Stock, Including Full Exercise Of Underwriters' Option

  • By Business Wire
  • May 18, 2020 4:05 PM EDT
PRESS RELEASES

Axcella Announces Pricing Of Public Offering Of Common Stock

  • By Business Wire
  • May 13, 2020 10:31 PM EDT
PRESS RELEASES

Axcella To Report Top-Line Data From AXA1125-003 In Adult Subjects With NAFLD On May 6, 2020

  • By Business Wire
  • May 5, 2020 4:05 PM EDT
PRESS RELEASES

Axcella To Hold Virtual-Only 2020 Annual Meeting Of Stockholders

  • By Business Wire
  • May 4, 2020 4:05 PM EDT
PRESS RELEASES

Axcella Receives Fourth Patent Covering EMM Compositions

  • By Business Wire
  • Apr 7, 2020 8:00 AM EDT
PRESS RELEASES

Axcella Completes Enrollment Of Subjects In AXA1665-002 Study

  • By Business Wire
  • Feb 26, 2020 7:30 AM EST
PRESS RELEASES

Axcella To Present At The SVB Leerink 9th Annual Global Healthcare Conference

  • By Business Wire
  • Feb 19, 2020 8:00 AM EST
PRESS RELEASES

Axcella To Present At J.P. Morgan Healthcare Conference

  • By Business Wire
  • Jan 9, 2020 8:00 AM EST
PRESS RELEASES

Axcella Announces Positive Interim Findings From Ongoing Clinical Study Of AXA1125/AXA1957 In Subjects With NAFLD And Expected 2020 Milestones

  • By Business Wire
  • Jan 8, 2020 8:00 AM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.